- Home
- ELVN vs UP Comparison
ELVN vs UP Comparison
Compare ELVN & UP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELVN
- UP
- Stock Information
- Founded
- ELVN 2016
- UP 2013
- Country
- ELVN United States
- UP United States
- Employees
- ELVN N/A
- UP N/A
- Industry
- ELVN Biotechnology: Pharmaceutical Preparations
- UP Aerospace
- Sector
- ELVN Health Care
- UP Consumer Discretionary
- Exchange
- ELVN Nasdaq
- UP Nasdaq
- Market Cap
- ELVN 1.0B
- UP 1.2B
- IPO Year
- ELVN 2020
- UP N/A
- Fundamental
- Price
- ELVN $22.54
- UP $1.44
- Analyst Decision
- ELVN Strong Buy
- UP
- Analyst Count
- ELVN 5
- UP 0
- Target Price
- ELVN $37.80
- UP N/A
- AVG Volume (30 Days)
- ELVN 269.1K
- UP 927.1K
- Earning Date
- ELVN 03-13-2025
- UP 03-06-2025
- Dividend Yield
- ELVN N/A
- UP N/A
- EPS Growth
- ELVN N/A
- UP N/A
- EPS
- ELVN N/A
- UP N/A
- Revenue
- ELVN N/A
- UP $833,669,000.00
- Revenue This Year
- ELVN N/A
- UP $38.03
- Revenue Next Year
- ELVN N/A
- UP $25.66
- P/E Ratio
- ELVN N/A
- UP N/A
- Revenue Growth
- ELVN N/A
- UP N/A
- 52 Week Low
- ELVN $10.90
- UP $1.45
- 52 Week High
- ELVN $30.03
- UP $4.59
- Technical
- Relative Strength Index (RSI)
- ELVN 47.03
- UP 32.84
- Support Level
- ELVN $20.40
- UP $1.45
- Resistance Level
- ELVN $22.42
- UP $1.65
- Average True Range (ATR)
- ELVN 1.25
- UP 0.06
- MACD
- ELVN 0.06
- UP 0.00
- Stochastic Oscillator
- ELVN 59.59
- UP 17.31
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage precision oncology company focused on the discovery and development of potentially first-in-class precision oncology therapies. Enliven's programs are designed to address issues such as tolerability, combinability, resistance and disease escape through brain metastases. Its product candidates include ELVN-001 which is a potent, selective, small molecule kinase inhibitor designed to specifically target the BCR-ABL gene fusion, the oncogenic driver for patients with chronic myeloid leukemia, and the ELVN-002 which is central nervous system (CNS) penetrant and irreversible HER2 inhibitor with activity against wild type HER2 and various HER2 mutations.
About UP Wheels Up Experience Inc.
Wheels Up Experience Inc is a provider of on-demand private aviation in the United States. It is pioneering data and technology-driven solutions that connect consumers to safety-vetted and verified private aircraft. It connects private flyers to aircraft, and one another, through an open platform that enables life's most important experiences. Its offering is delivered through a mix of programmatic and charter options that strategically utilize its owned and leased aircraft fleet and an "asset-light" charter model to deliver a greater range of global travel alternatives. The company operates in a single operating and reportable segment, private aviation services. Geographically the company generates the majority of its revenue from the United States.